Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage

Neurosurgery

Volumn 66, Issue 4, 2010, Pages 648-655

  Ducruet, Andrew F ^a   Hickman, Zachary L ^a   Zacharia, Brad E ^a   Grobelny, Bartosz T ^a   Narula, Reshma ^a   Guo, Kuang Hua ^a   Claassen, Jan ^a   Lee, Kiwon ^a   Badjatia, Neeraj ^a   Mayer, Stephan A ^a   Connolly, E Sander ^a  

^a Columbia University ^*  (United States)

Author keywords

Edema; Hemorrhage; Intraventricular; Tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ADVERSE DRUG REACTION; AGED; ASEPTIC MENINGITIS; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MEDICAL RECORD REVIEW; NEUROIMAGING; PERIHEMATOMAL EDEMA; PRIORITY JOURNAL; REVIEW; SHUNT DEPENDENCE; TREATMENT OUTCOME;

BRAIN EDEMA; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MENINGITIS; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77949967821     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000360374.59435.60     Document Type: Review

References (33)

1. Rankin J: Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 2:200-215, 1957.
2. Andrews CO, Engelhard HH: Fibrinolytic therapy in intraventricular hemorrhage. Ann Pharmacother 35:1435-1448, 2001.
3. Pang D, Sclabassi RJ, Horton JA: Lysis of intraventricular blood clot with urokinase in a canine model: Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery 19:553-572, 1986.
4. Steinke W, Sacco RL, Mohr JP, Foulkes MA, Tatemichi TK, Wolf PA, Price TR, Hier DB: Thalamic stroke. Presentation and prognosis of infarcts and hemorrhages. Arch Neurol 49:703-710, 1992.
5. Young WB, Lee KP, Pessin MS, Kwan ES, Rand WM, Caplan LR: Prognostic significance of ventricular blood in supratentorial hemorrhage: A volumetric study. Neurology 40:616-619, 1990.
6. Deutsch H, Rodriguez JC, Titton RL: Lower dose intraventricular T-PA fibrinolysis: Case report. Surg Neurol 61:460-463, 2004.
7. Engelhard HH, Andrews CO, Slavin KV, Charbel FT: Current management of intraventricular hemorrhage. Surg Neurol 60:15-22, 2003.
8. Findlay JM, Jacka MJ: Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage. Neurosurgery 55:532-538, 2004.
9. Findlay JM, Grace MG, Weir BK: Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery 32:941-947, 1993.
10. Haines SJ, Lapointe M: Fibrinolytic agents in the treatment of intraventricular hemorrhage in adults. Crit Rev Neurosurg 8:169-175, 1998.
11. Rohde V, Schaller C, Hassler WE: Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage. J Neurol Neurosurg Psychiatry 58:447-451, 1995.
12. Stolke D, Seifert V: Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: Preliminary assessment of efficacy and safety in an open clinical study. Neurosurgery 30:877-881, 1992.
13. Usui M, Saito N, Hoya K, Todo T: Vasospasm prevention with postoperative intrathecal thrombolytic therapy: A retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 34:235-245, 1994.
14. Varelas PN, Rickert KL, Cusick J, Hacein-Bey L, Sinson G, Torbey M, Spanaki M, Gennarelli TA: Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: Pilot study of treatment with intraventricular tissue plasminogen activator. Neurosurgery 56:205-213, 2005.
15. Morgan T, Awad I, Keyl P, Lane K, Hanley D: Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl 105:217-220, 2008.
16. Naff NJ, Carhuapoma JR, Williams MA, Bhardwaj A, Ulatowski JA, Bederson J, Bullock R, Schmutzhard E, Pfausler B, Keyl PM, Tuhrim S, Hanley DF: Treatment of intraventricular hemorrhage with urokinase: Effects on 30-day survival. Stroke 31:841-847, 2000.
17. Schwarz S, Schwab S, Steiner HH, Hacke W: Secondary hemorrhage after intraventricular fibrinolysis: A cautionary note: A report of two cases. Neurosurgery 42:659-663, 1998.
18. Goto H, Fujisawa H, Oka F, Nomura S, Kajiwara K, Kato S, FujII M, Maekawa T, Suzuki M: Neurotoxic effects of exogenous recombinant tissue-type plasminogen activator on the normal rat brain. J Neurotrauma 24:745-752, 2007.
19. Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, Andrae J, Gao Y, Pietras K, Mann K, Yepes M, Strickland DK, Betsholtz C, Eriksson U, Lawrence DA: Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14:731-737, 2008.
20. Wang YC, Lin CW, Shen CC, Lai SC, Kuo JS: Tissue plasminogen activator for the treatment of intraventricular hematoma: The dose-effect relationship. J Neurol Sci 202:35-41, 2002.
21. Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA: Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 112:1533-1540, 2003.
22. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M; American Heart Association/ American Stroke Association Stroke Council; American Heart Association/American Stroke Association High Blood Pressure Research Council; Quality of Care and Outcomes in Research Interdisciplinary Working Group: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 116:e391-e413, 2007.
23. Graeb DA, Robertson WD, Lapointe JS, Nugent RA, Harrison PB: Computed tomographic diagnosis of intraventricular hemorrhage. Etiology and prognosis. Radiology 143:91-96, 1982.
24. LeRoux PD, Haglund MM, Newell DW, Grady MS, Winn HR: Intraventricular hemorrhage in blunt head trauma: An analysis of 43 cases. Neurosurgery 31:678-685, 1992.
25. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J: The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304-1305, 1996.
26. Naval NS, Abdelhak TA, Urrunaga N, Zeballos P, Mirski MA, Carhuapoma JR: An association of prior statin use with decreased perihematomal edema. Neurocrit Care 8:13-18, 2008.
27. UK-TIA Study Group: United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Interim results. Br Med J (Clin Res Ed) 296:316-320, 1988.
28. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA: Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4:228-231, 1998.
29. Rohde V, Rohde I, Thiex R, Ince A, Jung A, Duckers G, Groschel K, Rottger C, Kuker W, Muller HD, Gilsbach JM: Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: Rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg 97:954-962, 2002.
30. Anonymous. The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis. Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. Br J Neurosurg 14:7-12, 2000.
31. Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ: Progression of mass effect after intracerebral hemorrhage. Stroke 30:1167-1173, 1999.
32. Naff NJ, Hanley DF, Keyl PM, Tuhrim S, Kraut M, Bederson J, Bullock R, Mayer SA, Schmutzhard E: Intraventricular thrombolysis speeds blood clot resolution: Results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 54:577-584, 2004.
33. Fountas KN, Kapsalaki EZ, Parish DC, Smith B, Smisson HF, Johnston KW, Robinson JS: Intraventricular administration of rt-PA in patients with intraventricular hemorrhage. South Med J 98:767-773, 2005.